Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3

  • Authors:
    • Virginia Lay
    • Joanne Yap
    • Stefan Sonderegger
    • Evdokia Dimitriadis
  • View Affiliations

  • Published online on: May 18, 2012     https://doi.org/10.3892/ijo.2012.1486
  • Pages: 759-764
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Endometrial carcinoma is the most common gynaecological malignancy. There is however a lack of curative therapies, especially for patients diagnosed with late stage, recurrent or aggressive disease, who have a poor prognosis. Interleukin (IL) 11 is a pleiotropic cytokine that has a role in a number of cancers including colon and breast cancer. IL11 was recently found to be upregulated in endometrial cancers, however the function of IL11 in endometrial cancer is not known. This study aimed to determine the effects of IL11 on endometrial cancer cell proliferation, adhesion and migration. Three endometrial cancer cell lines, Ishikawa, HEC-1A and AN3CA (derived from endometrial cancers grade I, II and III, respectively), were used to determine the effect of IL11 on endometrial cancer cell function. Cell proliferation and viability were assessed by BrdU and Wst-1 assays. Cell adhesion to the extracellular matrix proteins fibronectin, collagen I and IV, vitronectin and laminin was assessed. Modified boyden chambers were utilized to access IL11 action on migration and invasion, respectively. The specific effect of IL11 action on these processes was determined using a unique IL11 inhibitor. IL11 phosphorylated (p)-STAT3 protein abundance in all 3 cell lines but had no effect on pERK and pAKT abundance. Similarly, IL11 had no effect on cell proliferation and viability but increased adhesion of ANC3A cells to fibronectin while having no effect on the other extracellular matrix proteins. IL11 did not alter the adhesive properties of the Ishikawa and HEC-1A cells. In the AN3CA cells, IL11 treatment resulted in a 50% increase in migration and co-treatment with the specific IL11 inhibitor or a STAT3 inhibitor abolished the effect. This study shows a role for IL11 in endometrial cancer and suggests IL11 may be involved in endometrial cancer development and thus may be useful as a therapeutic target.
View Figures
View References

Related Articles

Journal Cover

August 2012
Volume 41 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lay V, Yap J, Sonderegger S and Dimitriadis E: Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. Int J Oncol 41: 759-764, 2012
APA
Lay, V., Yap, J., Sonderegger, S., & Dimitriadis, E. (2012). Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. International Journal of Oncology, 41, 759-764. https://doi.org/10.3892/ijo.2012.1486
MLA
Lay, V., Yap, J., Sonderegger, S., Dimitriadis, E."Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3". International Journal of Oncology 41.2 (2012): 759-764.
Chicago
Lay, V., Yap, J., Sonderegger, S., Dimitriadis, E."Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3". International Journal of Oncology 41, no. 2 (2012): 759-764. https://doi.org/10.3892/ijo.2012.1486